Clinical trial

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response…

NCT00263796 · Anagnostou, Evdokia, M.D., Other · Completed

Key facts

NCT number NCT00263796
Title An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism
Official title An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism
Lead sponsor Anagnostou, Evdokia, M.D., Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Autism
Intervention type Drug
Interventions Oxytocin, Placebo
Enrollment 16
Start date Mar 1, 2006
Primary completion Oct 1, 2010
Completion Sep 1, 2012
First posted Dec 9, 2005
Last update posted Apr 30, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies